91
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Effect of dyspnea on frailty stages and related factors in Taiwanese men with COPD

, , , &
Pages 2463-2469 | Published online: 15 Aug 2018

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 report)2018 Available from: http://goldcopd.orgAccessed 13 March, 2018
  • Bernabeu-MoraRGarcía-GuillamónGValera-NovellaEGiménez-GiménezLMEscolar-ReinaPMedina-MirapeixFFrailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal studyTher Adv Respir Dis2017111038339228849736
  • GaliziaGCacciatoreFTestaGRole of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary diseaseAging Clin Exp Res201123211812521743290
  • ParkSKRichardsonCRHollemanRGLarsonJLFrailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003–2006)Heart Lung201342316317023535142
  • AryalSDiaz-GuzmanEManninoDMInfluence of sex on chronic obstructive pulmonary disease risk and treatment outcomesInt J Chron Obstruct Pulmon Dis20149114525342899
  • LahousseLZiereGVerlindenVJRisk of frailty in elderly with COPD: a population-based studyJ Gerontol A Biol Sci Med Sci201671568969526355016
  • ErdfelderEFaulFBuchnerAGPOWER: A general power analysis programBehav Res Meth Instrum Computers1996281111
  • MahlerDAWellsCKEvaluation of clinical methods for rating dyspneaChest19889335805863342669
  • JonesPWHardingGBerryPDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
  • RadloffLSThe CES-D scale: a self-report depression scale for research in the general populationAppl Psychol Meas197713385401
  • ChanDCTsouHHChenCYChenCYValidation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone versionArch Gerontol Geriatr2010503e74e8019608288
  • LahousseLVerlindenVJvan der GeestJNGait patterns in COPD: the Rotterdam StudyEur Respir J2015461889525700390
  • BarrigaSRodriguesFBárbaraCFactors that influence physical activity in the daily life of male patients with chronic obstructive pulmonary diseaseRev Port Pneumol201420313113724418722
  • LandiFCalvaniRCesariMSarcopenia as the biological substrate of physical frailtyClin Geriatr Med201531336737426195096
  • DentELienCLimWSThe Asia-Pacific Clinical Practice Guidelines for the Management of FrailtyJ Am Med Dir Assoc201718756457528648901
  • DyerCThe interaction of ageing and lung diseaseChron Respir Dis201291636722308556
  • KojimaGIliffeSWaltersKSmoking as a predictor of frailty: a systematic reviewBMC Geriatr201515113126489757
  • MiravitllesMGarcía-SidroPFernández-NistalAThe chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPDInt J Chron Obstruct Pulmon Dis201510257126664105
  • HanMKQuibreraPMCarrettaEEFrequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortLancet Respir Med20175861962628668356
  • KellyJLBamseyOSmithCHealth status assessment in routine clinical practice: the chronic obstructive pulmonary disease assessment test score in outpatientsRespiration201284319319922441322
  • JonesPWBrusselleGdal NegroRWProperties of the COPD assessment test in a cross-sectional European studyEur Respir J2011381293521565915
  • TuYHZhangYFeiGHUtility of the CAT in the therapy assessment of COPD exacerbations in ChinaBMC Pulm Med20141414224618290
  • ChungHYCesariMAntonSMolecular inflammation: underpinnings of aging and age-related diseasesAgeing Res Rev200981183018692159
  • EspinozaSEFriedLPRisk factors for frailty in the older adultClin Geriat200715637
  • LangPOMichelJPZekryDFrailty syndrome: a transitional state in a dynamic processGerontology200955553954919346741
  • HubbardREO’MahonyMSSavvaGMCalverBLWoodhouseKWInflammation and frailty measures in older peopleJ Cell Mol Med2009139B3103310919438806
  • MangoniAAJacksonSHAge-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applicationsBr J Clin Pharmacol200457161414678335
  • FranssenFMSpruitMAWoutersEFDeterminants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011649322069360
  • JyrkkäJEnlundHKorhonenMJSulkavaRHartikainenSPatterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly personsDrugs Aging200926649350319591524
  • FrazierSCHealth outcomes and polypharmacy in elderly individualsJ Gerontol Nurs200531949
  • GnjidicDHilmerSNBlythFMHigh-risk prescribing and incidence of frailty among older community-dwelling menClin Pharmacol Ther201291352152822297385
  • GnjidicDHilmerSNBlythFMPolypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJ Clin Epidemiol201265998999522742913
  • FialováDTopinkováEGambassiGPotentially inappropriate medication use among elderly home care patients in EuropeJAMA2005293111348135815769968
  • GouldingMRInappropriate medication prescribing for elderly ambulatory care patientsArch Intern Med2004164330531214769626